VC  OrbiMed Advisors

https://www.orbimed.com/





     Office Locations:

12/F International Commerce Centre
1 Austin Road West, Unit 01
Kowloon,
Hong Kong

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Growth


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    OrbiMed is the world's largest healthcare-dedicated investment firm managing over $13 billion across public and private company investments worldwide. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds. OrbiMed seeks to be the capital provider of choice for life sciences companies pursuing growth and new opportunities. As a result of OrbiMed's growing capabilities in private equity, the firm launched a dedicated venture capital fund, Caduceus Private Investments, in 2000. Caduceus Private Investments II followed in 2003 and Caduceus Private Investments III was launched in 2006 with committed capital of over $500 million. In 2011 OrbiMed launched a Royalty Opportunities fund, focused on investing in healthcare royalty streams. Today, OrbiMed has a singular focus on seeking successful investments on a worldwide basis across the entire spectrum of private and publicly-traded life sciences companies. For privately-held companies, OrbiMed typically invests between $5 million and $40 million and the firm prefers mid-stage companies focused on drug development, drug discovery, and medical devices. The firm announced in Fall of 2013 the close of OrbiMed Private Investments V, LP, with just over $735 million in commitments, including approximately $36 million from the General Partner. In December 2015, the firm announced OrbiMed Private Investments VI, LP, with $950 million in limited partner commitments.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Carl L. Gordon Ph.D, CFA Managing Partner
    Daniel Rhee CISSP Chief Technology Officer
    Geoffrey C. Hsu CFA General Partner
    Jonathan T. Silverstein JD Managing Partner
    Mona Ashiya PhD Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/30/2024


      Leal Therapeutics


      MA


      $45,000,000


      


      10/02/2024


      Triveni Bio


      MA


      $115,000,000


      Series B


      08/05/2024


      MBX Biosciences


      IN


      $63,500,000


      Series C


      08/04/2024


      Scorpion Therapeutics


      MA


      $150,000,000


      Series C


      03/06/2024


      Sionna Therapeutics


      MA


      $182,000,000


      Series C


      02/13/2024


      ProfoundBio


      WA


      $112,000,000


      Series B


      02/13/2024


      BioAge Labs


      CA


      $170,000,000


      Series D


      01/16/2024


      Noctrix Health


      CA


      $40,000,000


      Series C


     

    Portfolio companies include:


      Acutus Medical
        web link


      Adagio Therapeutics
        web link


      ADARx Pharmaceuticals
        web link


      Adicet Bio


      Aduro BioTech
        web link


      Aeglea Biotherapeutics
        web link


      Aer Therapeutics
        web link


      Aerin Medical


      Aerpio Therapeutics
        web link


      Alector
        web link


      Alpine Immune Sciences
        web link


      Ambit Biosciences
        web link


      Aragon Pharmaceuticals
        web link


      ARMO Biosciences
        web link


      ArriVent Biopharma
        web link


      Arsanis
        web link


      Arvinas


      Aspen Neuroscience


      Atox Bio
        web link


      Attenua
        web link


      Audentes Therapeutics
        web link


      Augmedix
        web link


      Avedro
        web link


      Avitide
        web link


      BioAge Labs
        web link


      BlossomHill Therapeutics
        web link


      Capstan Therapeutics
        web link


      CardiAQ Valve Technologies
        web link


      Cardioxyl Pharmaceuticals


      Cerapedics
        web link


      Civitas Therapeutics
        web link


      Cleave Biosciences
        web link


      Compass Therapeutics
        web link


      Constellation Pharmaceuticals
        web link


      Convergent Therapeutics
        web link


      CoreMap


      Cyrus Biotechnology
        web link


      Cytek Biosciences
        web link


      Decibel Therapeutics
        web link


      Delfi Diagnostics
        web link


      Dimension Therapeutics
        web link


      Disc Medicine
        web link


      E-Scape Bio
        web link


      Edgewise Therapeutics
        web link


      Electra Therapeutics
        web link


      Erasca
        web link


      ESCAPE Bio
        web link


      Garuda Therapeutics
        web link


      Gemini Therapeutics
        web link


      GentiBio


      Good Start Genetics
        web link


      Graybug Vision
        web link


      Guardant Health
        web link


      Health Catalyst
        web link


      Iambic Therapeutics
        web link


      iECURE
        web link


      Igenica
        web link


      Imara
        web link


      ImmPACT Bio


      Inspire Medical
        web link


      Invitae


      Iroko Pharmaceuticals
        web link


      Janux Therapeutics
        web link


      Kala Pharmaceuticals
        web link


      Kinnate Biopharma
        web link


      Kyn Therapeutics
        web link


      Leal Therapeutics
        web link


      Loxo Oncology
        web link


      MBX Biosciences
        web link


      MID Labs
        web link


      Modis Therapeutics
        web link


      Natera
        web link


      Neurogastrx
        web link


      NeuroPace
        web link


      NextCure


      Noctrix Health
        web link


      OmniGuide
        web link


      ORIC Pharmaceuticals


      Otonomy
        web link


      Pandion Therapeutics
        web link


      Pathalys Pharma
        web link


      PIC Therapeutics
        web link


      Pionyr Immunotherapeutics
        web link


      PMV Pharma
        web link


      Practice Fusion
        web link


      Prelude Therapeutics
        web link


      Prevail Therapeutics
        web link


      Principia Biopharma


      ProfoundBio
        web link


      Promentis Pharmaceuticals
        web link


      Q32 Bio


      ReCode Therapeutics
        web link


      Relypsa
        web link


      resTORbio
        web link


      Rhythm
        web link


      SAGE Therapeutics
        web link


      Scorpion Therapeutics
        web link


      scPharmaceuticals
        web link


      Scribe Therapeutics
        web link


      Selecta
        web link


      Sikka Software
        web link


      Silverback Therapeutics
        web link


      Singulex
        web link


      Sionna Therapeutics
        web link


      Sonendo


      SpringWorks Therapeutics
        web link


      Symbiomix Therapeutics
        web link


      Syndax Pharmaceuticals
        web link


      Synlogic
        web link


      Synthorx
        web link


      Terns Pharmaceuticals
        web link


      Terremoto Biosciences
        web link


      Theseus Pharmaceuticals
        web link


      TigerText
        web link


      TP Therapeutics
        web link


      Tricida


      Triveni Bio
        web link


      True North Therapeutics


      Unum Therapeutics
        web link


      Upstream Bio
        web link


      VelosBio
        web link


      Vigil Neuroscience
        web link


     

    Recent News: